Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says

(May 19 00:37) Businessinsider.sg

Goldman Sachs raised the vaccine's probability of success to 75% from 70% and projected phase-two studies will begin this quarter.

You can find the original article here